ERN1
Basic information
Region (hg38): 17:64039080-64130819
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 43 | 47 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 5 | 2 |
Variants in ERN1
This is a list of pathogenic ClinVar variants found in the ERN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-64044010-G-T | not specified | Uncertain significance (Oct 25, 2023) | ||
17-64044134-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
17-64044143-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
17-64044167-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
17-64044176-C-T | not specified | Uncertain significance (Nov 15, 2023) | ||
17-64044184-T-C | not specified | Uncertain significance (Apr 25, 2022) | ||
17-64044871-T-C | not specified | Uncertain significance (Dec 15, 2022) | ||
17-64045389-G-A | not specified | Uncertain significance (Feb 13, 2024) | ||
17-64045445-C-T | not specified | Uncertain significance (Oct 06, 2023) | ||
17-64047885-G-C | not specified | Uncertain significance (Feb 12, 2024) | ||
17-64047911-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
17-64047941-C-A | not specified | Uncertain significance (Jan 04, 2022) | ||
17-64049098-G-A | Benign (Dec 13, 2017) | |||
17-64049157-C-T | not specified | Uncertain significance (Jan 24, 2023) | ||
17-64049169-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
17-64049178-C-A | not specified | Uncertain significance (Jun 24, 2022) | ||
17-64052782-G-C | not specified | Uncertain significance (Aug 14, 2023) | ||
17-64053368-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
17-64054748-T-C | not specified | Uncertain significance (Jan 08, 2024) | ||
17-64054814-C-G | not specified | Uncertain significance (Aug 09, 2021) | ||
17-64055677-C-T | not specified | Likely benign (Aug 16, 2022) | ||
17-64055695-G-A | not specified | Likely benign (Jan 04, 2024) | ||
17-64055698-G-C | Benign (Dec 13, 2017) | |||
17-64055743-T-G | not specified | Uncertain significance (Aug 13, 2021) | ||
17-64055764-G-A | not specified | Uncertain significance (Dec 20, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ERN1 | protein_coding | protein_coding | ENST00000433197 | 22 | 91678 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.990 | 0.00973 | 124647 | 0 | 11 | 124658 | 0.0000441 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.27 | 413 | 565 | 0.732 | 0.0000339 | 6326 |
Missense in Polyphen | 98 | 184.63 | 0.53078 | 2124 | ||
Synonymous | 0.254 | 236 | 241 | 0.979 | 0.0000161 | 1925 |
Loss of Function | 5.44 | 8 | 49.2 | 0.163 | 0.00000268 | 574 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000587 | 0.0000587 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000754 | 0.0000619 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase and endoribonuclease that acts as a key sensor for the endoplasmic reticulum unfolded protein response (UPR) (PubMed:11779464, PubMed:11175748, PubMed:12637535, PubMed:9637683, PubMed:21317875). In unstressed cells, the endoplasmic reticulum luminal domain is maintained in its inactive monomeric state by binding to the endoplasmic reticulum chaperone HSPA5/BiP (PubMed:21317875). Accumulation of misfolded protein in the endoplasmic reticulum causes release of HSPA5/BiP, allowing the luminal domain to homodimerize, promoting autophosphorylation of the kinase domain and subsequent activation of the endoribonuclease activity (PubMed:21317875). The endoribonuclease activity is specific for XBP1 mRNA and excises 26 nucleotides from XBP1 mRNA (PubMed:11779464, PubMed:24508390, PubMed:21317875). The resulting spliced transcript of XBP1 encodes a transcriptional activator protein that up-regulates expression of UPR target genes (PubMed:11779464, PubMed:24508390, PubMed:21317875). {ECO:0000269|PubMed:11175748, ECO:0000269|PubMed:11779464, ECO:0000269|PubMed:12637535, ECO:0000269|PubMed:21317875, ECO:0000269|PubMed:9637683, ECO:0000305|PubMed:24508390}.;
- Pathway
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Protein processing in endoplasmic reticulum - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);Alzheimer,s disease - Homo sapiens (human);Apoptosis - Homo sapiens (human);Alzheimers Disease;Corticotropin-releasing hormone signaling pathway;Apoptosis-related network due to altered Notch3 in ovarian cancer;Photodynamic therapy-induced unfolded protein response;VEGFA-VEGFR2 Signaling Pathway;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.311
Intolerance Scores
- loftool
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.63
Haploinsufficiency Scores
- pHI
- 0.179
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.392
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.988
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ern1
- Phenotype
- digestive/alimentary phenotype; immune system phenotype; embryo phenotype; liver/biliary system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- endothelial cell proliferation;mRNA cleavage;mRNA catabolic process;protein phosphorylation;cell cycle arrest;activation of JUN kinase activity;regulation of macroautophagy;endoplasmic reticulum unfolded protein response;positive regulation of RNA splicing;cellular response to unfolded protein;response to endoplasmic reticulum stress;cellular response to vascular endothelial growth factor stimulus;peptidyl-serine autophosphorylation;IRE1-mediated unfolded protein response;protein autophosphorylation;mRNA splicing, via endonucleolytic cleavage and ligation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;cellular response to glucose stimulus;RNA phosphodiester bond hydrolysis, endonucleolytic;mRNA cleavage involved in mRNA processing;positive regulation of endoplasmic reticulum unfolded protein response;insulin metabolic process;positive regulation of vascular smooth muscle cell proliferation;peptidyl-serine trans-autophosphorylation
- Cellular component
- nuclear inner membrane;cytoplasm;mitochondrion;endoplasmic reticulum;endoplasmic reticulum membrane;integral component of endoplasmic reticulum membrane;Ire1 complex;AIP1-IRE1 complex;IRE1-TRAF2-ASK1 complex;IRE1-RACK1-PP2A complex
- Molecular function
- magnesium ion binding;endoribonuclease activity;protein kinase activity;protein serine/threonine kinase activity;platelet-derived growth factor receptor binding;protein binding;ATP binding;enzyme binding;Hsp70 protein binding;identical protein binding;protein homodimerization activity;ADP binding;unfolded protein binding;Hsp90 protein binding